This inventor holds 16 USPTO granted patents. Top assignees: Balance Pharmaceuticals, Inc., Collagen Corporation, Target Therapeutics, Inc.. Active years: 1976-2007.
Location History:
- Menlo Park, CA (US) (1976 - 1980)
- Portola Valley, CA (US) (1981)
- Pacific Palisades, CA (US) (1984 - 2007)
Company Filing History:

Years Active: 1976-2007
Title: Innovations and Contributions of John R. Daniels
Introduction
John R. Daniels is a notable inventor based in Pacific Palisades, California. He has made significant contributions to the field of biomaterials and drug delivery systems. With a total of 16 patents to his name, his work has had a profound impact on various medical applications.
Latest Patents
One of his latest patents is titled "Compositions and methods of using a transient colorant." This invention focuses on creating biomaterials that incorporate a transient colorant for visualizing tissue or surgical materials. The applications of this invention include bioadhesives, tissue augmentation, prevention of surgical adhesions, coating surfaces of synthetic implants, and drug delivery matrices. Another significant patent is the "Nasal spray steroid formulation and method." This invention improves contraception methods and treatment for benign gynecological disorders through the intranasal administration of estrogenic and androgenic compounds, along with an optional progestin compound.
Career Highlights
Throughout his career, John R. Daniels has worked with prominent companies such as Target Therapeutics, Inc. and Collagen Corporation. His innovative approaches have led to advancements in medical technology and treatment methodologies.
Collaborations
He has collaborated with esteemed colleagues, including Edward E. Luck and Malcolm C. Pike. Their combined expertise has contributed to the success of various projects and inventions.
Conclusion
John R. Daniels is a distinguished inventor whose work in biomaterials and drug delivery systems continues to influence the medical field. His numerous patents and collaborations highlight his commitment to innovation and improving healthcare solutions.